Investor Relations
And information
HomeInvestor Relations› Wright Medical Group, Inc. Announces the Launch of PROPHECY(TM) Pre-Operative Navigation
News Releases
View printer-friendly version << Back
Wright Medical Group, Inc. Announces the Launch of PROPHECY(TM) Pre-Operative Navigation
ARLINGTON, Tenn., Apr 08, 2009 (BUSINESS WIRE) -- Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced today the full launch of its new PROPHECY(TM) Pre-Operative Navigation Guides for knee arthroplasty, recently previewed by the Company at the annual American Academy of Orthopaedic Surgeons meeting.

The PROPHECY(TM) program will enable surgeons to utilize basic CT or MRI scan technology to plan precise implant placement and alignment, before they enter the O.R. Therefore, surgeons will envision the results of surgery before it actually occurs. In contrast to utilizing traditional instruments to align the knee during surgery, the PROPHECY(TM) program utilizes computer imaging to develop patient-specific guides that follow the unique curvature of the patient's bone anatomy. "In many ways each patient's bone anatomy is like a fingerprint," said David DeBoer, M.D. of Nashville, Tennessee. "The guides produced by the PROPHECY(TM) program fit snugly onto the end of bone by matching the individual's very distinctive contour, ensuring the implant is positioned to match their own anatomical shape."

Simon Finger, M.D. of New Orleans, Louisiana, noted, "The process for the PROPHECY(TM) program begins weeks in advance. By applying this technology prior to the procedure, we enter into the operating room with a very well-defined plan with very accurate guides. Our goal is to increase accuracy while decreasing O.R. time." Once the procedure begins, patient-specific PROPHECY(TM) guides allow the surgeon to complete the implant placement with accuracy. By promoting accurate alignment, providing optimal sizing and guiding precision implant placement, Wright's new PROPHECY(TM) pre-operative navigation delivers reproducible surgical results for knee arthroplasty.

"Our goal is not only to improve accuracy and decrease patient anesthesia time, but to allow for greater function and long-term survival of the implants by placing them in a position for optimal mechanical function," explained Alex Winber, Wright's Director of OrthoRecon - Knees.

Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. The Company has been in business for more than 50 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit our website at

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends and may be identified by their use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," and other similar terms. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company's filings with the Securities and Exchange Commission (including the Company's annual report on Form 10-K for the year ended December 31, 2008, under the heading, "Risk Factors"), which could cause the Company's actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.

SOURCE: Wright Medical Group, Inc.

Wright Medical Group, Inc.
John K. Bakewell, 901-867-4527